A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice
About this item
Full title
Author / Creator
Vergani, Andrea , D'Addio, Francesca , Jurewicz, Mollie , Petrelli, Alessandra , Watanabe, Toshihiko , Liu, Kaifeng , Law, Kenneth , Schuetz, Christian , Carvello, Michele , Orsenigo, Elena , Deng, Shaoping , Rodig, Scott J , Ansari, Javeed M , Staudacher, Carlo , Abdi, Reza , Williams, John , Markmann, James , Atkinson, Mark , Sayegh, Mohamed H and Fiorina, Paolo
Publisher
United States: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
To investigate a new clinically relevant immunoregulatory strategy based on treatment with murine Thymoglobulin mATG Genzyme and CTLA4-Ig in NOD mice to prevent allo- and autoimmune activation using a stringent model of islet transplantation and diabetes reversal.
Using allogeneic islet transplantation models as well as NOD mice with recent onse...
Alternative Titles
Full title
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice
Authors, Artists and Contributors
Author / Creator
D'Addio, Francesca
Jurewicz, Mollie
Petrelli, Alessandra
Watanabe, Toshihiko
Liu, Kaifeng
Law, Kenneth
Schuetz, Christian
Carvello, Michele
Orsenigo, Elena
Deng, Shaoping
Rodig, Scott J
Ansari, Javeed M
Staudacher, Carlo
Abdi, Reza
Williams, John
Markmann, James
Atkinson, Mark
Sayegh, Mohamed H
Fiorina, Paolo
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2927948
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2927948
Other Identifiers
ISSN
0012-1797
E-ISSN
1939-327X
DOI
10.2337/db09-1264
